About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,985 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,985 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1001-1020 of 7,985 trials

UnknownA Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLCThe purpose of this study is is to assess the safety and tolerability of curcumin in combination with EGFR-TKIs in selected patients with advanced non-resectable mutant EGFR NSCLC.NCT02321293·Montreal, Quebec CompletedCombination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC PatientsThe third generation epidermal growth factor receptor-tyrosine Kinase Inhibitor（EGFR-TKI） osimertinib has obvious curative effect for EGFR sensitive mutation and T790M…NCT04184921·Chongqing, Chongqing Municipality CompletedA Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung CancerThe purpose of this study is to evaluate the efficacy of anti-emetic drug Aprepitant upon the combination chemotherapy of nedaplatin and docetaxel for non-small cell lung cancer…NCT02364804·Ōtsu, Shiga Not yet recruitingExploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorThe goal of this clinical trial is to learn if Trastuzumab Rezetecan can treat advanced solid tumors with HER-2 expression in adult participants.NCT07631884

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

Not yet recruitingHigh-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal MetastasisPrimary Objective: To evaluate the efficacy of high-dose firmonertinib combined with bevacizumab and intrathecal pemetrexed in EGFR Ex19del/L858R-mutated non-small cell lung…NCT06971406

Active not recruitingBI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid TumorsThe goal of this first in human clinical trial is to test BI-1910 administered as single agent and in combination with pembrolizumab in subjects with advanced/metastatic solid…NCT06205706·Copenhagen and 7 others

RecruitingImmunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung CancerThis study aims to evaluate the efficacy of immunonutrition in reducing acute esophagitis after thoracic radiotherapy in lung cancer.NCT06840704·Changsha, Hunan and 5 others

RecruitingAlectinib Pharmacokinetic in Patients With NSCLCThis interventional study aims to determine the pharmacokinetics of orally administered alectinib with dose escalation from 300 mg to 600 mg twice daily in Mexican patients with…NCT05713006·Mexico City, Mexico City

WithdrawnA Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung CancerThe purpose of this trial is to measure ALA-induced fluorescence in both normal and malignant tissue.NCT01611584·Lebanon, New Hampshire

CompletedStudy Of SU011248 In Combination With Docetaxel In Patients With Advanced CancerThis study is determining the maximum tolerated dose and safety of SU011248 (sunitinib malate, SUTENT) in combination with docetaxel (Taxotere).NCT00712504·Birmingham, Alabama and 4 others

UnknownLocal Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line TherapyThis is a prospective single arme real-world study clinical study, which aims to investigate the overall benefit and safety of consolidative therapy in advanced NSCLC (stage…NCT03046316·Guangzhou, Guagndong

UnknownStudy of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLCEvaluate the efficacy and safety of Anlotinib plus Icotinib as the first-line treatment in patients with sensitive EGFR concomitant mutations advanced non-small cell lung cancerNCT04797806·Tianjin, Tianjin Municipality

CompletedA Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor (HER)2 Immunohistochemistry (IHC)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)This is a Phase 2, multicenter study designed to evaluate the efficacy and safety of trastuzumab emtansine administered as a single-agent in participants with HER2-positive (HER2…NCT02289833·Jacksonville, Florida and 22 others

TerminatedPhase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer PatientsNivolumab is superior to docetaxel monotherapy as second line treatment in advanced stage non-small cell lung cancer (NSCLC) patients.NCT03509584·Marseille

RecruitingSCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung CancerThis is a multicenter Phase II/III study evaluating the efficacy and safety of SCTB41 combined with chemotherapy versus tislelizumab combined with chemotherapy as first-line…NCT07662395·Guangzhou, Guangdong

UnknownThe Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung CancerThe development of anti-angiogenesis drugs has led to renewed enthusiasm in lung cancer treatments.NCT02733107·Chongqing, Chongqing Municipality

CompletedPhase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung CancerThe purpose of this phase 1b/2 study is to estimate the treatment effect of study drug measuring progression free survival.NCT01666977·Fayetteville, Arkansas and 34 others

UnknownOsimertinib as First-line Therapy for Patients With Late-stage Lung CancerBased on the existing research results, Osimertinibi is effective not only for patients with sensitizing EGFR mutations, but also for other less common EGFR mutations.NCT03460275·Guangzhou, Guangdong and 1 other

RecruitingExploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLCTo investigate genomic architecture, cancer evolution and their relationship with clinical outcomes in EGFR-mutant NSCLC.NCT05997719·Guanzhou

Active not recruitingLazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior LazertinibThis trial is Phase II Trial of Lazertinib+Pemetrexed/Carboplatin in Patients with EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to…NCT05786430·Seoul

PreviousPage 51 of 400Next